Pharmaco-economics of community maintenance for opiate dependence: A review of evidence and methodology

Drug and Alcohol Dependence

Volumn 84, Issue 1, 2006, Pages 28-39

  Simoens, Steven ^a   Ludbrook, Anne ^b   Matheson, Catriona ^c   Bond, Christine ^c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Community maintenance; Economic evaluation; Opiate dependence

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE; NALOXONE; OPIATE;

ABSTINENCE; COCHRANE LIBRARY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DATA ANALYSIS; DRUG COST; DRUG DETOXIFICATION; EMBASE; HUMAN; INFORMATION RETRIEVAL; LENGTH OF STAY; MAINTENANCE THERAPY; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; METHADONE TREATMENT; OPIATE ADDICTION; PATIENT COUNSELING; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PSYCINFO; QUALITY ADJUSTED LIFE YEAR; REFERENCE DATABASE; REVIEW;

BUPRENORPHINE; COMMUNITY MENTAL HEALTH SERVICES; COST-BENEFIT ANALYSIS; EVALUATION STUDIES; EVALUATION STUDIES AS TOPIC; HEALTH STATUS; HUMANS; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS;

EID: 33746668763     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.12.009     Document Type: Review

References (35)

1. Abbott P.J., Weller S.B., Delaney H.D., and Moore B.A. Community reinforcement approach in the treatment of opiate addicts. Am. J. Drug Alcohol Abuse. 24 (1998) 1-10
2. Avants S.K., Margolin A., Sindelar J.L., Rounsaville B.J., Schottenfeld R., Stine S., Cooney N.L., Rosenheck R.A., Li S.H., and Kosten T.R. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Am. J. Psychiatry 156 (1999) 27-33
3. Barnett P.G. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction 94 (1999) 479-488
4. Barnett P.G., and Hui S.S. The cost-effectiveness of methadone maintenance. Mt. Sinai J. Med. 67 (2000) 365-374
5. Barnett P.G., Zaric G.S., and Brandeau M.L. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction 96 (2001) 1267-1278
6. Blume A.W. Treating Drug Problems (2005), John Wiley & Sons, Chichester
7. Briggs A.H., O'Brien B.J., and Blackhouse G. Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annu. Rev. Public Health 23 (2002) 377-401
8. Dijkgraaf M.G.W., van der Zanden B.P., de Borgie C.A.J.M., Blanken P., van Ree J.M., and van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. Br. Med. J. 330 (2005) 1297
9. Doran C.M., Shanahan M., Mattick R.P., Ali R., White J., and Bell J. Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug Alcohol Depend. 71 (2003) 295-302
10. Drummond M., O'Brien B., Stoddart G., and Torrance G. Methods for the Economic Evaluation of Health Care Programmes (1997), Oxford University Press, Oxford
11. Fiellin D.A., O'Connor P.G., Chawarski M., Pakes J.P., Pantalon M.V., and Schottenfeld R.S. Methadone maintenance in primary care. A randomised controlled trial. J. Am. Med. Assoc. 286 (2001) 1724-1731
12. Flynn P.M., Porto J.V., Rounds-Bryant J.L., and Kristiansen P.L. Costs and benefits of methadone treatment in DATOS. Part 1. Discharged versus continuing patients. J. Maintenance Addict. 20 (2003) 129-150
13. Gerstein D.R., and Harwood H.J. Treating Drug Problems vol. 2 (1992), National Academies Press, Washington, DC
14. Godfrey C., Stewart D., and Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction 99 (2004) 697-707
15. Gossop M., Marsden J., and Stewart D. NTORS After Five Years: Changes in Substance Use, Health and Criminal Behaviour During the Five Years After Intake (2001), Department of Health, London
16. Gruber K., Chutuape M.A., and Stitzer M.L. Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation. Drug Alcohol Depend. 57 (2000) 211-223
17. Harris A.H., Gospodarevskaya E., and Ritter A.J. A randomized trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics 23 (2005) 77-91
18. Healey A., Knapp M., Marsden J., Gossop M., and Stewart D. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey. J. Health Serv. Res. Pol. 8 (2003) 134-141
19. Koenig L., Denmead G., Nguyen R., Harrison M., and Harwood H. The costs and benefits of substance abuse treatment: findings from the National Treatment Improvement Evaluation Study (NTIES). Department of Health and Human Services (1999), SAMHSA, Rockville
20. Kraft M.K., Rothbard A.B., Hadley T.R., McLellan A.T., and Asch D.A. Are supplementary services provided during methadone maintenance really cost-effective?. Am. J. Psychiatry 154 (1997) 1214-1219
21. Mark T.L., Woody G.E., Juday T., and Kleber H.D. The economic costs of heroin addiction in the United States. Drug Alcohol Depend. 61 (2001) 195-206
22. Masson C.L., Barnett P.G., Sees K.L., Delucchi K.L., Rosen A., Wong W., and Hall S.M. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction 99 (2004) 718-726
23. Mattick R.P., Kimber J., Breen C., and Davoli M. Buprenorphine Maintenance Versus Placebo or Methadone Maintenance for Opioid Dependence. The Cochrane Database of Systematic Reviews (2003), John Wiley & Sons, Chichester
24. McCusker J., Bigelow C., Vickers-Lahti M., Spotts D., Garfield F., and Frost R. Planned duration of residential drug abuse treatment: efficacy versus effectiveness. Addiction 92 (1997) 1467-1478
25. Miller C.L., Schechter M.T., Wood E., Spittal P.M., Li K., Laliberté N., Montaner J.S., and Hogg R.S. The potential health and economic impact of implementing a medically prescribed heroin program among Canadian injection drug users. Int. J. Drug Pol. 15 (2004) 259-263
26. Nemes S., Wish E.D., and Messina N. Comparing the impact of standard and abbreviated treatment in a therapeutic community. Findings from the District of Columbia treatment initiative experiment. J. Subst. Abuse Treat. 17 (1999) 339-347
27. Nordlund D.J., Estee S., Mancuso D., and Felver B. Methadone Treatment for Opiate Addiction Lowers Health Care Costs and Reduces Arrests and Convictions (2004), Washington State Department of Social and Health Services, Washington
28. Owens D.K. Interpretation of cost-effectiveness analyses. J. Gen. Intern. Med. 13 (1998) 716-717
29. Pani P.P., Maremmani I., Pirastu R., Tagliamonte A., and Gessa G.L. Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Drug Alcohol Depend. 60 (2000) 39-50
30. Perneger T.V., Giner F., del Rio M., and Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. Br. Med. J. 317 (1998) 13-18
31. Rosenheck R., and Kosten T. Buprenorphine for opiate addiction: potential economic impact. Drug Alcohol Depend. 63 (2001) 253-262
32. Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., Banys P., and Hall S.M. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence. J. Am. Med. Assoc. 283 (2000) 1303-1310
33. Simoens S., Matheson C., Bond C., Inkster K., and Ludbrook A. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. Br. J. Gen. Pract. 55 (2005) 139-146
34. Strang J., Marsden J., Cummins M., Farrell M., Finch E., Gossop M., Stewart D., and Welch S. Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome. Addiction 95 (2000) 1631-1645
35. Zaric G.S., Barnett P.G., and Brandeau M.L. HIV transmission and the cost-effectiveness of methadone maintenance. Am. J. Public Health 90 (2000) 1100-1111